Citi downgraded Avantor to Neutral from Buy with a price target of $23, down from $30.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVTR:
- Avantor Announces Executive Vice President’s Departure
- Avantor added to ‘Tactical Outperform’ list, target trimmed at Evercore ISI
- Avantor launches J.T.Baker Cell Lysis Solution, J.T.Baker Endonuclease
- Avantor price target lowered to $25 from $28 at Barclays
- Avantor Announces Executive Leadership Reshuffle